Financial reports
ARS
2023 FY
Annual report to shareholders
15 Apr 24
10-K
2023 FY
Annual report
15 Mar 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
17 Apr 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial ResultsĀ and Provides Current Business Update
13 Mar 24
8-K
Completion of Acquisition or Disposition of Assets
4 Mar 24
8-K
Departure of Directors or Certain Officers
22 Feb 24
8-K
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
5 Feb 24
8-K
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
22 Jan 24
8-K
Results of Operations and Financial Condition
9 Jan 24
8-K
Other Events
9 Jan 24
8-K
Other Events
26 Dec 23
8-K
Departure of Directors or Certain Officers
11 Dec 23
8-K
Departure of Directors or Certain Officers
7 Dec 23
Registration and prospectus
S-8
Registration of securities for employees
28 Mar 24
424B5
Prospectus supplement for primary offering
12 Sep 23
424B3
Prospectus supplement
26 Jul 23
S-4
Registration of securities issued in business combination transactions
7 Jul 23
425
Business combination disclosure
16 Jun 23
425
Business combination disclosure
16 Jun 23
425
Business combination disclosure
16 Jun 23
425
Business combination disclosure
16 Jun 23
425
Business combination disclosure
16 Jun 23
Proxies
DEFA14A
Additional proxy soliciting materials
15 Apr 24
DEF 14A
Definitive proxy
15 Apr 24
DEFA14A
Additional proxy soliciting materials
17 Apr 23
DEF 14A
Definitive proxy
17 Apr 23
DEFA14A
Additional proxy soliciting materials
4 Apr 22
DEF 14A
Definitive proxy
4 Apr 22
DEFA14A
Additional proxy soliciting materials
9 Apr 21
DEF 14A
Definitive proxy
9 Apr 21
DEFA14A
Additional proxy soliciting materials
12 May 20
DEFA14A
Additional proxy soliciting materials
8 Apr 20
Other
EFFECT
Notice of effectiveness
27 Jul 23
CORRESP
Correspondence with SEC
24 Jul 23
UPLOAD
Letter from SEC
14 Jul 23
EFFECT
Notice of effectiveness
18 Nov 22
CORRESP
Correspondence with SEC
15 Nov 22
UPLOAD
Letter from SEC
14 Nov 22
UPLOAD
Letter from SEC
20 Apr 22
CORRESP
Correspondence with SEC
20 Apr 22
UPLOAD
Letter from SEC
7 Apr 22
CORRESP
Correspondence with SEC
30 Dec 21
Ownership
4
Georgia Erbez
22 Feb 24
3
Georgia Erbez
22 Feb 24
4
Mats Wahlstrom
15 Feb 24
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 24
SC 13G/A
ALLIANCEBERNSTEIN L.P.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Mats Wahlstrom
5 Feb 24
SC 13G/A
BlackRock Inc.
24 Jan 24
4
Dennis M Lanfear
23 Jan 24
4
Paul Reider
23 Jan 24